Early Decisions and Impact: Risankizumab in Bio-Naive Patients With PsA Sponsored by AbbVie Medical Affairs + Health Impact

Mar 02, 2026 6:12 am
Early Decisions and Impact: Risankizumab in Bio-Naive Patients With PsA Sponsored by AbbVie Medical Affairs + Health Impact by Dr. Cush

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Subscribe and Rate

Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen in the car, airplane, anywhere! We also reach more listeners through reviews from our users. Consider leaving a review!
 

 

×